EA202190698A1 - HUMANIZED ANTI-C5 ANTIBODIES AND THEIR APPLICATION - Google Patents

HUMANIZED ANTI-C5 ANTIBODIES AND THEIR APPLICATION

Info

Publication number
EA202190698A1
EA202190698A1 EA202190698A EA202190698A EA202190698A1 EA 202190698 A1 EA202190698 A1 EA 202190698A1 EA 202190698 A EA202190698 A EA 202190698A EA 202190698 A EA202190698 A EA 202190698A EA 202190698 A1 EA202190698 A1 EA 202190698A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibodies
application
humanized anti
complement
antibody
Prior art date
Application number
EA202190698A
Other languages
Russian (ru)
Inventor
Вэньчао СУН
Такаси МИВА
Дамодар ГУЛЛИПАЛЛИ
Пин Цзуи
Саяка Сато
Original Assignee
Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания
КЕРА ФАРМАСЬЮТИКАЛЗ (ЮэС) ЭлЭлСи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания, КЕРА ФАРМАСЬЮТИКАЛЗ (ЮэС) ЭлЭлСи filed Critical Дзе Трастиз Оф Дзе Юниверсити Оф Пенсильвания
Priority claimed from PCT/US2019/049890 external-priority patent/WO2020051418A1/en
Publication of EA202190698A1 publication Critical patent/EA202190698A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Настоящее изобретение относится к ингибированию передачи сигнала комплемента с помощью анти-C5 антитела. В частности, изобретение относится к способам лечения комплемент-опосредованного заболевания или комплемент-опосредованного расстройства у индивидуума путем контактирования индивидуума с анти-C5 антителом.The present invention relates to the inhibition of complement signaling by an anti-C5 antibody. In particular, the invention relates to methods of treating a complement-mediated disease or complement-mediated disorder in an individual by contacting the individual with an anti-C5 antibody.

EA202190698A 2019-04-24 2019-09-06 HUMANIZED ANTI-C5 ANTIBODIES AND THEIR APPLICATION EA202190698A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962837833P 2019-04-24 2019-04-24
PCT/US2019/049890 WO2020051418A1 (en) 2018-09-06 2019-09-06 Humanized anti-c5 antibodies and uses thereof

Publications (1)

Publication Number Publication Date
EA202190698A1 true EA202190698A1 (en) 2021-06-10

Family

ID=76805190

Family Applications (2)

Application Number Title Priority Date Filing Date
EA202190698A EA202190698A1 (en) 2019-04-24 2019-09-06 HUMANIZED ANTI-C5 ANTIBODIES AND THEIR APPLICATION
EA202192911A EA202192911A1 (en) 2019-04-24 2020-04-24 BIFUNCTIONAL HUMANIZED ANTI-C5 ANTIBODIES AND FACTOR H FUNCTION PROTEINS AND THEIR APPLICATIONS

Family Applications After (1)

Application Number Title Priority Date Filing Date
EA202192911A EA202192911A1 (en) 2019-04-24 2020-04-24 BIFUNCTIONAL HUMANIZED ANTI-C5 ANTIBODIES AND FACTOR H FUNCTION PROTEINS AND THEIR APPLICATIONS

Country Status (1)

Country Link
EA (2) EA202190698A1 (en)

Also Published As

Publication number Publication date
EA202192911A1 (en) 2022-03-24

Similar Documents

Publication Publication Date Title
EA201992091A1 (en) ANTI-C5 ANTIBODIES AND THEIR APPLICATION
MX2021002710A (en) Humanized anti-c5 antibodies and uses thereof.
EA202092839A1 (en) PSMA LINKING AGENTS AND THEIR APPLICATIONS
EA201992248A1 (en) ANTI-C5a-ANTIBODIES AND THEIR APPLICATION
MX2021012997A (en) Bi-functional humanized anti-c5 antibodies and factor h fusion proteins and uses thereof.
EA201890162A1 (en) ANTIBODIES TO CD40 WITH ENHANCED AGONISTIC ACTIVITY
EA201792221A1 (en) ANTIBODIES AGAINST SORTILINE AND METHODS OF THEIR APPLICATION
PE20190261A1 (en) ANTIBODIES THAT RECOGNIZE TAU
EA201890175A1 (en) ANTIBODIES TO CD40
EA202091130A1 (en) LYOPHILIZED PREPARATION OF MONOCLONAL ANTIBODY TO TRANSTYRETIN
EA202092420A1 (en) ANTIBODY AGAINST PD-L1 AND ITS APPLICATION
EA201891925A1 (en) ANTIBODIES TO CD40 WITH STRENGTHENED AGONISTIC ACTIVITY
EA201992206A1 (en) MONOCLONAL ANTIBODY TO PD-L1
EA202190138A1 (en) ANTI-SIRP-BETA1 ANTIBODIES AND METHODS OF THEIR USE
EA201991876A1 (en) ANTIBODIES AGAINST FACTOR D AND THEIR APPLICATION
AR112563A1 (en) MONOCLONAL ANTI-SORTILINE ANTIBODIES USEFUL IN THE CORRECTION OF A POOR PROGRANULIN LEVEL (PGRN)
EA202192907A1 (en) MONOCLONAL ANTIBODY THAT SPECIFICLY BINDS TO GITR
EA202190183A1 (en) ANTIBODIES TO SIGLEC-5 AND METHODS OF THEIR APPLICATION
ZA202205288B (en) Humanized antibody and method for using the same
EA202190698A1 (en) HUMANIZED ANTI-C5 ANTIBODIES AND THEIR APPLICATION
EA202092595A1 (en) ANTIBODIES TO SIGLEC-7 AND METHODS OF THEIR APPLICATION
EA202191173A1 (en) A MONOCLONAL ANTIBODY THAT BINDS SPECIFICALLY CD20
EA202090309A1 (en) ANTI-TIGIT ANTIBODIES
EA202090864A1 (en) MONOCLONAL ANTIBODY TO IL-5R
MX2024003769A (en) Humanized anti-c5a antibodies and uses thereof.